Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Shares Rise 9 Percent

Shares of Bruker BioSciences climbed 9.1 percent for the five-day trading week ended Tuesday, leading all gainers in the BCW Index. The only other stock in the Index to gain more than 5 percent for the week was that of Illumina, which rose 5.4 percent.
 
Caliper Life Sciences led decliners for the week, dropping 6.6 percent.
 
Overall, the Index gained 1.1 percent. In comparison, the Dow Jones Industrial Average fell 1 percent, the Nasdaq declined 1.2 percent, and the Nasdaq Biotech Index gained 1.2 percent.

 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price
(Sept. 11, 2007)
Starting Price
(
Sept. 4, 2007)
% change
Affymetrix
AFFX
23.41
23.51
-0.43
Agilent
A
36.31
36.4
-0.25
Applied Biosystems
ABI
32.1
32.23
-0.40
Beckman
BEC
72.25
72.02
0.32
Becton Dickinson
BDX
77.71
77.02
0.90
Bio-Rad
BIO
85.56
85.67
-0.13
Bruker
BRKR
7.68
7.04
9.09
Caliper
CALP
5.41
5.79
-6.56
Cepheid
CPHD
20.01
20.17
-0.79
Illumina
ILMN
51.43
48.78
5.43
Invitrogen
IVGN
81.52
79.1
3.06
Luminex
LMNX
14.99
14.45
3.74
MDS
MDZ
20.69
19.87
4.13
Millipore
MIL
73.63
71.89
2.42
PerkinElmer
PKI
27.42
27.48
-0.22
Qiagen
QGEN
17.11
17.12
-0.06
Sequenom
SQNM
5.05
5.07
-0.39
Sigma-Aldrich
SIAL
43.86
44.9
-2.32
Thermo
TMO
54.5
54.54
-0.07
Third Wave
TWTI
8.11
7.75
4.65
Waters
WAT
63.62
62.44
1.89
BCW Index Average  
39.16
38.73
1.12
The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.